Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 6 of 11 for:    CRS-207

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03190265
Recruitment Status : Recruiting
First Posted : June 16, 2017
Last Update Posted : August 20, 2021
Aduro Biotech, Inc.
Bristol-Myers Squibb
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2023
Estimated Study Completion Date : October 2023